论文信息 - Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study - 字舞流文

Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

D. Podzamczer | E. Ribera | S. Moreno | J. Troya | P. Ryan | J. Berenguer | A. Imaz | H. Knobel | I. Suárez-Lozano | J. González-García | H. Esteban | M. Galindo | V. Boix | V. Hontañón | J. A. Terrón | A. Carrero | P. Barrufet | M. Raffo | M. Castaño | J. Solís | M. Yllescas